Alo Nag

Prof. Alo Nag


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
DNDeeptashree Nandi
Deeptashree Nandi
PCPradeep Singh Cheema
Pradeep Singh Cheema
NJNeha Jaiswal
Neha Jaiswal
ANAlo Nag
Alo Nag

1 February 2014 in Open Biology
Verified
Journal Article
Open access
PSPuneet Sharma
Puneet Sharma
ANAlo Nag
Alo Nag
The ability of cullin 4A (CUL4A), a scaffold protein, to recruit a repertoire of substrate adaptors allows it to assemble into distinct E3 ligase complexes to mediate turnover of key regulatory proteins. In the past decade, a considerable wealth of information has been generated regarding its biology, regulation, assembly, molecular architecture and novel functions. Importantly, unravelling of its association with multiple tumours and modulation by viral proteins establishes it as one of the key proteins that may play an important role in cellular transformation. Considering the role of its substrate in regulating the cell cycle and maintenance of genomic stability, understanding the detailed aspects of these processes will have significant consequences for the treatment of cancer and related diseases. This review is an effort to provide a broad overview of this multifaceted ubiquitin ligase and addresses its critical role in regulation of important biological processes. More importantly, its tremendous potential to be exploited for therapeutic purposes has been discussed.

1 May 2021 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
JCJatin Chadha
Jatin Chadha
DNDeeptashree Nandi
Deeptashree Nandi
YAYama Atri
Yama Atri
ANAlo Nag
Alo Nag

9 June 2021 in Open Biology
Verified
Journal Article
Open access
PCPradeep Singh Cheema
Pradeep Singh Cheema
DNDeeptashree Nandi
Deeptashree Nandi
ANAlo Nag
Alo Nag
The COVID-19 pandemic has wreaked unprecedented societal havoc worldwide. The infected individuals may present mild to severe symptoms, with nearly 20% of the confirmed patients impaired with significant complications, including multi-organ failure. Acute respiratory distress imposed by SARS-CoV-2 largely results from an aggravated cytokine storm and deregulated immune response. The forkhead box O (FoxO) transcription factors are reported to play a significant role in maintaining normal cell physiology by regulating survival, apoptosis, oxidative stress, development and maturation of T and B lymphocytes, secretion of inflammatory cytokines, etc. We propose a potent anti-inflammatory approach based on activation of the FoxO as an attractive strategy against the novel coronavirus. This regime will be focused on restoring redox and inflammatory homeostasis along with repair of the damaged tissue, activation of lymphocyte effector and memory cells. Repurposing FoxO activators as a means to alleviate the inflammatory burst following SARS-CoV-2 infection can prove immensely valuable in the ongoing pandemic and provide a reliable groundwork for enriching our repertoire of antiviral modalities for any such complication in the future. Altogether, our review highlights the possible efficacy of FoxO activation as a novel arsenal for clinical management of COVID-19.

2 December 2014 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
MRMohsin Raza
Mohsin Raza
SCSankalpa Chakraborty
Sankalpa Chakraborty
MCMonjoy Choudhury
Monjoy Choudhury
PGPrahlad C. Ghosh
Prahlad C. Ghosh
ANAlo Nag
Alo Nag
Iron metabolism and homeostasis are imperative for the maintenance of normal physiological activities due to the element’s critical involvement in a wide variety of crucial biological processes like cellular respiration, metabolic pathways, DNA replication, repair, detoxification, neurotransmission and cellular signaling. Being a key contributor of crucial machineries regulating cellular proliferation and survival, it facilitates the process of tumor growth and development. Thus, tumor cells strive to acquire higher amount of iron than non-malignant cells to satisfy their elevated rate of metabolism. Perhaps, not surprisingly chelation of this metal ion was thought to be effective in treating cancer, but due to a variety of side effects, the use of iron chelators was clinically insignificant. However, discovery of various new classes of iron chelators with lesser side effects and selective toxicity towards cancer cells has revived the possibilities of using iron chelators in anti-cancer therapy. In this review, we have discussed the role of iron in promoting malignant mechanisms and the prospects of usage of different classes of iron chelators in cancer therapeutics.

1 May 2021 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
ICINDRANIL CHATTOPADHYAY
INDRANIL CHATTOPADHYAY
DNDeeptashree Nandi
Deeptashree Nandi
ANAlo Nag
Alo Nag